INTRODUCTION
Carswell et al (1) identified a cytotoxin (CTX) in the sera of mice infected with Bacillus Calmette-Guerin (BCG) and subsequently treated with endotoxin which they called TNF because of its ability to induce selective tumour necrosis.
It has been subsequently found that activated macrophages are the major cellular source of TNF (2) and that, in addition to its selective cytotoxicity, it has other profound biological effects (3) . Several of these effects have been ascertained using highly purified rTNF derived from E.coli (4, 5) . The availability of TNF-specific neutralising antibodies has also aided elucidation of the various biological properties of TNF (6) (7) (8) (9) (10) .
In this study we set out to prepare anti-human TNF monoclonal antibodies (McAbs), for which, to our knowledge, there are as yet few reports on their actual preparation and characterization (11, 12) , in order to learn more about the antigenic structure of TNF and to prepare reagents for TNF quantification by imrounoassay.
MATERIALS AND METHODS

Antibody Preparation
Recombinant human TNF (BASF Knoll (15, 18) . Using a method previously described for HuIFN" (15) , rTNF-specific polyclonal antibodies attached to etched polystyrene beads were first incubated with rTNF (0.1-5000 units/ml; 2-105pg/ml) and secondly with 125I-anti-rTNF McAb Fig 1(A) . The (Fig 1(A) Fig KB) . The detection Figure 1(A) . Calibration curves generated in IRMA with serial two-fold dilutions of purified rTNF (1-5000 units/ml) using rabbit polyclonal anti-rTNF on the bead and l25i- 3 
